Q32 Bio (QTTB) Free Cash Flow (2017 - 2026)
Q32 Bio's quarterly Free Cash Flow came in at -$6.5 million in Q1 2026, up 48.79% year-on-year from -$4.4 million in Q1 2025, and up 8.72% quarter-over-quarter from -$7.1 million in Q4 2025.
Q32 Bio has reported Free Cash Flow for 10 years, with the latest figure at -$6.5 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 48.79% year-over-year to -$6.5 million; the trailing twelve-month figure through Mar 2026 stood at -$28.3 million (up 57.04% YoY), and the FY2025 full-year result was -$34.5 million, up 49.1% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$6.5 million, up from -$7.1 million in the prior quarter.
- The five-year high for Free Cash Flow was $16.1 million in Q3 2023, with the low at -$32.1 million in Q2 2022.
- Average Free Cash Flow over 5 years is -$14.3 million, with a median of -$12.5 million recorded in 2023.
- Year-over-year, Free Cash Flow jumped 164.53% in 2023 and sank 222.96% in 2024.
- Tracing QTTB's Free Cash Flow over 5 years: stood at -$27.2 million in 2022, then surged by 60.62% to -$10.7 million in 2023, then dropped by 1.74% to -$10.9 million in 2024, then soared by 34.49% to -$7.1 million in 2025, then increased by 8.72% to -$6.5 million in 2026.
- The last three Free Cash Flow figures came in at -$6.5 million (Q1 2026), -$7.1 million (Q4 2025), and -$4.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | -6.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.52 Mn |
| Mar 31, 2026 | -6.52 Mn |
| Dec 31, 2025 | -7.14 Mn |
| Dec 31, 2025 | -7.14 Mn |
| Sep 30, 2025 | -4.23 Mn |
| Sep 30, 2025 | -4.23 Mn |
| Jun 30, 2025 | -10.40 Mn |
| Jun 30, 2025 | -10.40 Mn |
| Mar 31, 2025 | -12.73 Mn |
| Mar 31, 2025 | -12.73 Mn |
| Dec 31, 2024 | -10.90 Mn |
| Dec 31, 2024 | -10.90 Mn |
| Sep 30, 2024 | -19.79 Mn |
| Sep 30, 2024 | -19.79 Mn |
| Jun 30, 2024 | -22.44 Mn |
| Jun 30, 2024 | -22.44 Mn |
| Mar 31, 2024 | -14.67 Mn |
| Mar 31, 2024 | -14.67 Mn |
| Dec 31, 2023 | -10.72 Mn |
| Dec 31, 2023 | -10.72 Mn |
| Sep 30, 2023 | 16.09 Mn |
| Sep 30, 2023 | 16.09 Mn |
| Jun 30, 2023 | -11.56 Mn |
| Jun 30, 2023 | -11.56 Mn |
| Mar 31, 2023 | -12.50 Mn |
| Mar 31, 2023 | -12.50 Mn |
| Dec 31, 2022 | -27.21 Mn |
| Dec 31, 2022 | -27.21 Mn |
| Sep 30, 2022 | -24.94 Mn |
| Sep 30, 2022 | -24.94 Mn |
| Jun 30, 2022 | -32.06 Mn |
| Jun 30, 2022 | -32.06 Mn |
| Mar 31, 2022 | -30.74 Mn |
| Mar 31, 2022 | -30.74 Mn |
| Dec 31, 2021 | -30.64 Mn |
| Dec 31, 2021 | -30.64 Mn |
| Sep 30, 2021 | -25.33 Mn |
| Sep 30, 2021 | -25.33 Mn |
| Jun 30, 2021 | -23.39 Mn |
| Jun 30, 2021 | -23.39 Mn |
| Mar 31, 2021 | -30.64 Mn |
| Mar 31, 2021 | -30.64 Mn |
| Dec 31, 2020 | -8.94 Mn |
| Dec 31, 2020 | -8.94 Mn |
| Sep 30, 2020 | -29.04 Mn |
| Sep 30, 2020 | -29.04 Mn |
| Jun 30, 2020 | -30.20 Mn |
| Jun 30, 2020 | -30.20 Mn |
| Mar 31, 2020 | -26.25 Mn |
| Mar 31, 2020 | -26.25 Mn |
| Dec 31, 2019 | -26.11 Mn |
| Dec 31, 2019 | -26.11 Mn |
| Sep 30, 2019 | -9.78 Mn |
| Sep 30, 2019 | -9.78 Mn |
| Jun 30, 2019 | -32.78 Mn |
| Jun 30, 2019 | -32.78 Mn |
| Mar 31, 2019 | -23.15 Mn |
| Mar 31, 2019 | -23.15 Mn |
| Dec 31, 2018 | -24.01 Mn |
| Dec 31, 2018 | -24.01 Mn |
| Sep 30, 2018 | -18.52 Mn |
| Sep 30, 2018 | -18.52 Mn |
| Jun 30, 2018 | -13.90 Mn |
| Jun 30, 2018 | -13.90 Mn |
| Mar 31, 2018 | -11.07 Mn |
| Mar 31, 2018 | -11.07 Mn |
| Dec 31, 2017 | 21.71 Mn |
| Dec 31, 2017 | 21.71 Mn |
| Sep 30, 2017 | -6.92 Mn |
| Sep 30, 2017 | -6.92 Mn |
| Jun 30, 2017 | -4.89 Mn |
| Jun 30, 2017 | -4.89 Mn |
| Mar 31, 2017 | -5.37 Mn |
| Mar 31, 2017 | -5.37 Mn |